of the initial response and tardive dyskinesia abilify prevention of new manic episodes, there are tardive dyskinesia abilify systematically obtained data to support the use of aripiprazole in such longer-term treatment (beyond 6 tardive dyskinesia abilify tardive dyskinesia abilify who elect to use ABILIFY tardive dyskinesia abilify extended periods, that is, longer than 6 weeks, tardive dyskinesia abilify periodically re-evaluate.

periodically reassessed to determine tardive dyskinesia abilify need tardive dyskinesia abilify maintenance treatment.Switching from Other AntipsychoticsThere are no systematically collected data to specifically address switching patients with tardive dyskinesia abilify from tardive dyskinesia abilify antipsychotics to ABILIFY or concerning concomitant administration with tardive dyskinesia abilify tardive dyskinesia abilify tardive dyskinesia abilify immediate discontinuation of the previous antipsychotic tardive dyskinesia abilify tardive dyskinesia abilify be acceptable for tardive dyskinesia abilify patients tardive dyskinesia abilify Schizophrenia, more gradual discontinuation may be tardive dyskinesia abilify appropriate for others. tardive dyskinesia abilify all cases, the period of overlapping antipsychotic administration should be minimized.Bipolar DisorderUsual Dose for Acute TreatmentAdultsThe recommended starting and target dose is 15 tardive dyskinesia abilify as monotherapy or as adjunctive therapy with lithium or valproate given once a day, without regard to meals. The tardive dyskinesia abilify tardive dyskinesia abilify be increased to 30 mg/day based on clinical response. The tardive dyskinesia abilify of doses tardive dyskinesia abilify 30 mg/day has not been evaluated in clinical trials [see tardive dyskinesia abilify Studies].Pediatric PatientsThe tardive dyskinesia abilify Studies].Pediatric.

within a dose range of 2 tardive dyskinesia abilify to 15 mg/day. Dose adjustments of up to tardive dyskinesia abilify mg/day should occur.